𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Conditional survival in patients treated with vascular endothelial growth factor-targeted therapy for advanced renal cell carcinoma

✍ Scribed by Y. Zhu, Y. P. Hong, H. L. Zhang, G. H. Shi, W. J. Xiao, Z. H. Wang, X. D. Yao, S. L. Zhang, B. Dai, D. W. Ye

Book ID
118785463
Publisher
Springer-Verlag
Year
2012
Tongue
English
Weight
377 KB
Volume
138
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical factors associated with outcome
Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to